Lipoprotein (a) testing patterns among subjects with a measured lipid panel: The Mayo Clinic experience
Testing rates for Lp(a) in the general population are low and the main setting remains secondary prevention. Women are less tested than men. When Lp(a) is found to be elevated, often times there is no change in patient management to mitigate the ASCVD risk.
Authors
- Leslie J. Donato (ORCID: https://orcid.org/0000-0003-0126-7623)
- Vlad C. Vasile (ORCID: https://orcid.org/0000-0001-5447-8091)
- Allan S. Jaffe (ORCID: https://orcid.org/0000-0003-1183-3959)
- Jeffrey W. Meeusen (ORCID: https://orcid.org/0000-0002-0784-034X)
- Matteo Manzato
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- American Journal of Preventive Cardiology
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.ajpc.2024.100886
- Citations
- 7
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 4.01